Douglas Dolfi is currently the Director of Strategic Planning at Merck, where they are leveraging their expertise in immuno-oncology and targeted drug development. With a Ph.D. in Immunology from Drexel University College of Medicine, Douglas has held various scientific roles, including positions as a Research Scientist at The Janssen Pharmaceutical Companies and as a Postdoctoral Fellow at both The Wistar Institute and the University of Pennsylvania. Their extensive experience encompasses T and NK cell-directed modalities and emphasizes the integration of pre-clinical and clinical data to advance life-changing therapies for cancer patients.
This person is not in the org chart
This person is not in any teams
This person is not in any offices